Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FYCRW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,243
Award facts
- Contract value 100% obligated
- $5,243.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $5,243.37 and is scheduled for completion by September 23, 2025. The contract was issued without a set-aside designation, and performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat inflammatory conditions, reflecting the breadth of pharmaceutical products that AmerisourceBergen supplies to federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract serves as the primary vehicle for AmerisourceBergen to supply pharmaceutical products and medical supplies to support military and veteran healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive portfolio of competitively awarded delivery orders covering diverse therapeutic categories and price points, demonstrating its established capability to meet federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FYCRW?
SPE2DB25FYCRW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FYCRW worth?
The government has obligated $5,243 on SPE2DB25FYCRW.
Is contract SPE2DB25FYCRW an order under another contract?
Yes. SPE2DB25FYCRW is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB25FYCRW competed?
The extent of competition for SPE2DB25FYCRW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award